ERAS Forecast


Bullish Case: Erasca (ERAS) shows strong potential with notable insider buying worth $3.97M and positive sentiment around its licensing of new cancer drugs. The current pipeline's refresh and recent price rise of 65.9% over the past 60 days establish solid momentum.


Bearish Case: Despite the recent gains, ERAS faces significant headwinds, including high implementation costs, ongoing regulatory hurdles, and recent layoffs. Historical data suggests a high likelihood of negative returns, indicating vulnerability to market and operational risks.


Potential Outcomes:

1. Approval of ERAS-801 (60%): Short-term boost.

2. Positive naporafenib trial results (50%): Medium-term potential.

3. High implementation costs limiting adoption (50%): Bearish.

4. Regulatory delays/failures (30%): Bearish impact.

5. Market consolidation boosts stock (25%): Bullish.


Trading Oracle: Sell credit spreads (Helium Short Volatility). Bearish short-term outlook due to regulatory uncertainties and high historical volatility. Preferred trade: ERAS 2.50 Put credit spreads, leveraging high implied volatility and minimizing risk. Timeframe: Next 3-6 months.


July 16, 2024


Erasca Forecast

ERAS      Erasca











Correlated Assets

Assets that tend to move strongly with ERAS



VTYX Forecast + Options Trading Strategies   VTYX  Ventyx Biosciences (0.77)


BABA Forecast + Options Trading Strategies   BABA  Alibaba (0.74)


EBS Forecast + Options Trading Strategies   EBS  Emergent Biosolutions (0.73)


SNBR Forecast + Options Trading Strategies   SNBR  Sleep Number (0.73)


NTR Forecast + Options Trading Strategies   NTR  Nutrien (0.72)



Uncorrelated Assets

Assets with little price relationship to ERAS



WMT Forecast + Options Trading Strategies   WMT  Walmart (-0.0)


KNX Forecast + Options Trading Strategies   KNX  Knight-Swift Transportation (-0.0)


ZG Forecast + Options Trading Strategies   ZG  Zillow (-0.0)


GT Forecast + Options Trading Strategies   GT  Goodyear Tire & Rubber (-0.0)


TGTX Forecast + Options Trading Strategies   TGTX  TG Therapeutics (-0.0)



Anticorrelated Assets

Assets that tend to move strongly against ERAS



SUN Forecast + Options Trading Strategies   SUN  Sunoco (-0.68)


ESTC Forecast + Options Trading Strategies   ESTC  Elastic (-0.69)


AMR Forecast + Options Trading Strategies   AMR  Alta Mesa Resources (-0.7)


UEC Forecast + Options Trading Strategies   UEC  Uranium Energy (-0.71)


AFRM Forecast + Options Trading Strategies   AFRM  Affirm (-0.71)





Become a more profitable investor with AI optimized trading strategies






×

Chat with ERAS


 Ask any question about ERAS!